“…The commercial manufacturing process for daclatasvir (trade name Daklinza) involves multistep reaction protocols such as a C-C coupling reaction to make the core biphenyl moiety, bromination, N-Boc-L-proline coupling, imidazole formation, Boc deprotection, and Moc-L-valine coupling, and then conversion into the corresponding dihydrochloride salt. 1,2 For the synthesis of the biaryl core moiety, several C-C coupling reactions have been extensively studied in the presence of transition metals, including Au, 3 Pd, [4][5][6][7][8] Rh, 9 Ru, 10 Ir, 11 Ni, [12][13][14] and Cu. 15 Additionally, external oxidants such as benzoquinone or copper acetate 4 and reductants such as zinc, magnesium, hydroquinone, or ascorbic acid 4 are needed for changing the oxidation state of the transition-metal catalyst and initiating the formation of the aryl intermediate involving an electron-transfer pro-cess.…”